| 1 |
Saha B, Roy A, Beltramo E, Sahoo OS. Stem cells and diabetic retinopathy: From models to treatment. Mol Biol Rep 2023. [PMID: 36842153 DOI: 10.1007/s11033-023-08337-0] [Reference Citation Analysis]
|
| 2 |
Lupo G, Agafonova A, Cosentino A, Giurdanella G, Mannino G, Lo Furno D, Romano IR, Giuffrida R, D'Angeli F, Anfuso CD. Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy. Int J Mol Sci 2023;24. [PMID: 36674425 DOI: 10.3390/ijms24020913] [Reference Citation Analysis]
|
| 3 |
Zhu L, Wang S, Qu J, Hui Z, Kan C, Hou N, Sun X. The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus. Cell Reprogram 2022;24:329-42. [PMID: 35877064 DOI: 10.1089/cell.2022.0039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Chen X, Jiang Y, Duan Y, Zhang X, Li X. Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases. Genes 2022;13:1901. [DOI: 10.3390/genes13101901] [Reference Citation Analysis]
|
| 5 |
Rasiah PK, Jha KA, Gentry J, Del Mar NA, Townsend T, Torgbe KE, Reiner A, Gangaraju R. A Long-Term Safety and Efficacy Report on Intravitreal Delivery of Adipose Stem Cells and Secretome on Visual Deficits After Traumatic Brain Injury. Transl Vis Sci Technol 2022;11:1. [PMID: 36180031 DOI: 10.1167/tvst.11.10.1] [Reference Citation Analysis]
|
| 6 |
Ma J, Lei P, Chen H, Wang L, Fang Y, Yan X, Yang Q, Peng B, Jin L, Sun D. Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases. Front Pharmacol 2022;13:986683. [DOI: 10.3389/fphar.2022.986683] [Reference Citation Analysis]
|
| 7 |
Gao S, Mo L, Li M, Zou T, Xu H. Effects of interaction between stem cells and degenerative retinal microenvironment on stem cell fate determination. Sci Sin -Vitae 2022;52:1041-1059. [DOI: 10.1360/ssv-2021-0075] [Reference Citation Analysis]
|
| 8 |
Liu S, Ju Y, Gu P. Experiment-Based Interventions to Diabetic Retinopathy: Present and Advances. IJMS 2022;23:7005. [DOI: 10.3390/ijms23137005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Mannino G, Cristaldi M, Giurdanella G, Perrotta RE, Lo Furno D, Giuffrida R, Rusciano D. ARPE-19 conditioned medium promotes neural differentiation of adipose-derived mesenchymal stem cells. World J Stem Cells 2021;13:1783-96. [PMID: 34909123 DOI: 10.4252/wjsc.v13.i11.1783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Agrawal M, Rasiah PK, Bajwa A, Rajasingh J, Gangaraju R. Mesenchymal Stem Cell Induced Foxp3(+) Tregs Suppress Effector T Cells and Protect against Retinal Ischemic Injury. Cells 2021;10:3006. [PMID: 34831229 DOI: 10.3390/cells10113006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 11 |
Al-Sowayan BS, Al-Shareeda AT. Stem cells and the pursuit of youth, a tale of limitless possibilities and commercial fraud. World J Biol Chem 2021; 12(4): 52-56 [PMID: 34354805 DOI: 10.4331/wjbc.v12.i4.52] [Reference Citation Analysis]
|
| 12 |
Sharma A, Jaganathan BG. Stem Cell Therapy for Retinal Degeneration: The Evidence to Date. Biologics 2021;15:299-306. [PMID: 34349498 DOI: 10.2147/BTT.S290331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Mannino G, Russo C, Longo A, Anfuso CD, Lupo G, Lo Furno D, Giuffrida R, Giurdanella G. Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases. World J Stem Cells 2021;13:632-44. [PMID: 34249232 DOI: 10.4252/wjsc.v13.i6.632] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 14 |
Mannino G, Longo A, Gennuso F, Anfuso CD, Lupo G, Giurdanella G, Giuffrida R, Lo Furno D. Effects of High Glucose Concentration on Pericyte-Like Differentiated Human Adipose-Derived Mesenchymal Stem Cells. Int J Mol Sci 2021;22:4604. [PMID: 33925714 DOI: 10.3390/ijms22094604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Holan V, Palacka K, Hermankova B. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials. Cells 2021;10:588. [PMID: 33799995 DOI: 10.3390/cells10030588] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 16 |
Wen YT, Ho YC, Lee YC, Ding DC, Liu PK, Tsai RK. The Benefits and Hazards of Intravitreal Mesenchymal Stem Cell (MSC) Based-Therapies in the Experimental Ischemic Optic Neuropathy. Int J Mol Sci 2021;22:2117. [PMID: 33672743 DOI: 10.3390/ijms22042117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 17 |
Goenka V, Borkar T, Desai A, Das RK. Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases. J Diabetes Metab Disord 2020;19:1979-93. [PMID: 33520872 DOI: 10.1007/s40200-020-00647-5] [Reference Citation Analysis]
|
| 18 |
Lin Y, Ren X, Chen Y, Chen D. Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment. Front Neurosci 2020;14:617377. [PMID: 33551729 DOI: 10.3389/fnins.2020.617377] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Elshaer SL, Park HS, Pearson L, Hill WD, Longo FM, El-Remessy AB. Modulation of p75NTR on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model. Int J Mol Sci 2021;22:E829. [PMID: 33467640 DOI: 10.3390/ijms22020829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Li XJ, Li CY, Bai D, Leng Y. Insights into stem cell therapy for diabetic retinopathy: a bibliometric and visual analysis. Neural Regen Res 2021;16:172-8. [PMID: 32788473 DOI: 10.4103/1673-5374.286974] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 21 |
Alonso-Alonso ML, Srivastava GK, Usategui-Martín R, García-Gutierrez MT, Pastor JC, Fernandez-Bueno I. Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases. Stem Cells Int 2020;2020:9463548. [PMID: 32676122 DOI: 10.1155/2020/9463548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Shen Y, Shen H, Guo D, Sun X, Sun Y, Hong N, Wang X, Xie C, Zhao Y, He Q, Jin L, Wen Y, Jiang B, Yu C, Zhu M, Cai F, Dai J. Recent developments in regenerative ophthalmology. Sci China Life Sci 2020;63:1450-90. [PMID: 32621058 DOI: 10.1007/s11427-019-1684-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 23 |
Yang H, Wu L, Deng H, Chen Y, Zhou H, Liu M, Wang S, Zheng L, Zhu L, Lv X. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia. J Neuroinflammation 2020;17:154. [PMID: 32393298 DOI: 10.1186/s12974-020-1731-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 24 |
Huang H, Kolibabka M, Eshwaran R, Chatterjee A, Schlotterer A, Willer H, Bieback K, Hammes H, Feng Y. Intravitreal injection of mesenchymal stem cells evokes retinal vascular damage in rats. The FASEB Journal 2019;33:14668-79. [DOI: 10.1096/fj.201901500r] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 25 |
Jha KA, Pentecost M, Lenin R, Gentry J, Klaic L, Del Mar N, Reiner A, Yang CH, Pfeffer LM, Sohl N, Gangaraju R. TSG-6 in conditioned media from adipose mesenchymal stem cells protects against visual deficits in mild traumatic brain injury model through neurovascular modulation. Stem Cell Res Ther 2019;10:318. [PMID: 31690344 DOI: 10.1186/s13287-019-1436-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 26 |
Gaddam S, Periasamy R, Gangaraju R. Adult Stem Cell Therapeutics in Diabetic Retinopathy. Int J Mol Sci. 2019;20. [PMID: 31575089 DOI: 10.3390/ijms20194876] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 27 |
Solis MA, Moreno Velásquez I, Correa R, Huang LLH. Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America. Diabetol Metab Syndr 2019;11:20. [PMID: 30820250 DOI: 10.1186/s13098-019-0415-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
